Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 133
Filtrar
1.
J Autoimmun ; 147: 103246, 2024 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-38788540

RESUMO

OBJECTIVES: Systemic sclerosis (SSc) is a multiorgan disease with a 10-year mortality rate of up to 50 %. B cell-depleting therapy with rituximab (RTX) appears effective in SSc treatment, but data from randomized controlled trials (RCTs) are lacking, and the frequency and dosage of RTX in SSc have no consensus. We aimed to evaluate the long-term efficacy and safety of quarterly RTX administration in SSc. METHODS: This study retrospectively analyzed 40 patients with SSC treated with RTX twice within 14 days every 3 months from 2010 to 2020. The patients fulfilled the LeRoy and the American College of Rheumatology/European League Against Rheumatism Criteria for SSc. Modified Rodnan skin score (mRSS), lung function test results, and serum immunoglobulin (IgG, IgA, and IgM) concentrations were analyzed. RESULTS: A total of 40 patients with SSc received RTX over a median time of 3.9 years (range: 1-10 years). The median mRSS (baseline: 19, 24 months: 16, p < 0.001) demonstrated a significant improvement, and the predicted forced vital capacity was stable. No new or unexpected safety signals, especially regarding treatment-related infectious adverse events, were observed. Immunoglobulin concentrations were within normal range, and specific antibodies to pneumococcal polysaccharides were preserved despite long-term B cell-depleting therapy. None of the patients died during the observation period of up to 10 years. CONCLUSION: SSc was effectively and safely treated with low-dose RTX quarterly. RCTs are warranted to validate the advantage of continuous B cell depletion by quarterly low-dose RTX administration compared to other treatment intervals.


Assuntos
Linfócitos B , Depleção Linfocítica , Rituximab , Escleroderma Sistêmico , Humanos , Escleroderma Sistêmico/mortalidade , Escleroderma Sistêmico/imunologia , Escleroderma Sistêmico/terapia , Escleroderma Sistêmico/tratamento farmacológico , Feminino , Masculino , Pessoa de Meia-Idade , Linfócitos B/imunologia , Rituximab/uso terapêutico , Estudos Retrospectivos , Adulto , Resultado do Tratamento , Idoso
2.
Vet Pathol ; 53(2): 277-90, 2016 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-26869153

RESUMO

Aging is the biological process of declining physiologic function associated with increasing mortality rate during advancing age. Humans and higher nonhuman primates exhibit unusually longer average life spans as compared with mammals of similar body mass. Furthermore, the population of humans worldwide is growing older as a result of improvements in public health, social services, and health care systems. Comparative studies among a wide range of organisms that include nonhuman primates contribute greatly to our understanding about the basic mechanisms of aging. Based on their genetic and physiologic relatedness to humans, nonhuman primates are especially important for better understanding processes of aging unique to primates, as well as for testing intervention strategies to improve healthy aging and to treat diseases and disabilities in older people. Rhesus and cynomolgus macaques are the predominant monkeys used in studies on aging, but research with lower nonhuman primate species is increasing. One of the priority topics of research about aging in nonhuman primates involves neurologic changes associated with cognitive decline and neurodegenerative diseases. Additional areas of research include osteoporosis, reproductive decline, caloric restriction, and their mimetics, as well as immune senescence and chronic inflammation that affect vaccine efficacy and resistance to infections and cancer. The purpose of this review is to highlight the findings from nonhuman primate research that contribute to our understanding about aging and health span in humans.


Assuntos
Envelhecimento/patologia , Primatas/fisiologia , Pesquisa , Envelhecimento/genética , Animais , Humanos , Macaca fascicularis , Macaca mulatta , Modelos Animais , Primatas/genética
3.
Mucosal Immunol ; 9(4): 1089-101, 2016 07.
Artigo em Inglês | MEDLINE | ID: mdl-26647718

RESUMO

Innate immune responses have a critical role in the control of early virus replication and dissemination. It remains unknown, however, how severe acute respiratory syndrome coronavirus (SARS-CoV) evades respiratory innate immunity to establish a systemic infection. Here we show in Chinese macaques that SARS-CoV traversed the mucosa through the respiratory tract within 2 days, resulting in extensive mucosal infiltration by T cells, MAC387(+), and CD163(+) monocytes/macrophages followed by limited viral replication in the lung but persistent viral shedding into the upper airway. Mucosal monocytes/macrophages sequestered virions in intracellular vesicles together with infected Langerhans cells and migrated into the tonsils and/or draining lymph nodes within 2 days. In lymphoid tissues, viral RNA and proteins were detected in infected monocytes upon differentiation into dendritic cells (DCs) within 3 days. Systemic viral dissemination was observed within 7 days. This study provides a comprehensive overview of the spatiotemporal interactions of SARS-CoV, monocytes/macrophages, and the DC network in mucosal tissues and highlights the fact that, while these innate cells contribute to viral clearance, they probably also serve as shelters and vehicles to provide a mechanism for the virus to escape host mucosal innate immunity and disseminate systemically.


Assuntos
Coronavirus/fisiologia , Células Dendríticas/imunologia , Macaca mulatta/imunologia , Macrófagos/imunologia , Mucosa Respiratória/imunologia , Síndrome Respiratória Aguda Grave/imunologia , Linfócitos T/imunologia , Animais , Diferenciação Celular , Movimento Celular , Células Cultivadas , Células Dendríticas/virologia , Humanos , Evasão da Resposta Imune , Imunidade Inata , Macrófagos/virologia , RNA Viral/imunologia , Mucosa Respiratória/virologia , Linfócitos T/virologia , Carga Viral , Replicação Viral , Eliminação de Partículas Virais
4.
Br J Cancer ; 107(12): 1978-86, 2012 Dec 04.
Artigo em Inglês | MEDLINE | ID: mdl-23169291

RESUMO

BACKGROUND: Activins control the growth of several tumour types including thoracic malignancies. In the present study, we investigated their expression and function in malignant pleural mesothelioma (MPM). METHODS: The expression of activins and activin receptors was analysed by quantitative PCR in a panel of MPM cell lines. Activin A expression was further analysed by immunohistochemistry in MPM tissue specimens (N=53). Subsequently, MPM cells were treated with activin A, activin receptor inhibitors or activin-targeting siRNA and the impact on cell viability, proliferation, migration and signalling was assessed. RESULTS: Concomitant expression of activin subunits and receptors was found in all cell lines, and activin A was overexpressed in most cell lines compared with non-malignant mesothelial cells. Similarly, immunohistochemistry demonstrated intense staining of tumour cells for activin A in a subset of patients. Treatment with activin A induced SMAD2 phosphorylation and stimulated clonogenic growth of mesothelioma cells. In contrast, treatment with kinase inhibitors of activin receptors (SB-431542, A-8301) inhibited MPM cell viability, clonogenicity and migration. Silencing of activin A expression by siRNA oligonucleotides further confirmed these results and led to reduced cyclin D1/3 expression. CONCLUSION: Our study suggests that activin A contributes to the malignant phenotype of MPM cells via regulation of cyclin D and may represent a valuable candidate for therapeutic interference.


Assuntos
Ativinas/antagonistas & inibidores , Antineoplásicos/farmacologia , Ciclina D/metabolismo , Mesotelioma/metabolismo , Mesotelioma/patologia , Neoplasias Pleurais/metabolismo , Neoplasias Pleurais/patologia , Western Blotting , Movimento Celular , Proliferação de Células , Sobrevivência Celular , Ciclina D/efeitos dos fármacos , Regulação Neoplásica da Expressão Gênica , Inativação Gênica , Humanos , Imuno-Histoquímica , Mesotelioma/tratamento farmacológico , Fenótipo , Fosforilação/efeitos dos fármacos , Neoplasias Pleurais/tratamento farmacológico , RNA Interferente Pequeno/farmacologia , Reação em Cadeia da Polimerase em Tempo Real , Transdução de Sinais/efeitos dos fármacos , Proteína Smad2/metabolismo , Ensaio Tumoral de Célula-Tronco , Regulação para Cima
5.
Cold Spring Harb Perspect Med ; 2(9): a007005, 2012 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-22951442

RESUMO

Human immunodeficiency virus (HIV) pathogenesis has proven to be quite complex and dynamic with most of the critical events (e.g., transmission, CD4(+) T-cell destruction) occurring in mucosal tissues. In addition, although the resulting disease can progress over years, it is clear that many critical events happen within the first few weeks of infection when most patients are unaware that they are infected. These events occur predominantly in tissues other than the peripheral blood, particularly the gastrointestinal tract, where massive depletion of CD4(+) T cells occurs long before adverse consequences of HIV infection are otherwise apparent. Profound insights into these early events have been gained through the use of nonhuman primate models, which offer the opportunity to examine the early stages of infection with the simian immunodeficiency virus (SIV), a close relative of HIV that induces an indistinguishable clinical picture from AIDS in Asian primate species, but importantly, fails to cause disease in its natural African hosts, such as sooty mangabeys and African green monkeys. This article draws from data derived from both human and nonhuman primate studies.


Assuntos
Infecções por HIV/virologia , HIV/patogenicidade , Animais , Fármacos Anti-HIV/uso terapêutico , Translocação Bacteriana/imunologia , Linfócitos T CD4-Positivos/imunologia , Linfócitos T CD4-Positivos/virologia , Modelos Animais de Doenças , Infecções por HIV/tratamento farmacológico , Infecções por HIV/imunologia , Humanos , Síndrome Inflamatória da Reconstituição Imune/induzido quimicamente , Imunidade Celular , Imunidade Inata/fisiologia , Imunidade nas Mucosas/fisiologia , Macaca , Primatas , Síndrome de Imunodeficiência Adquirida dos Símios/imunologia , Síndrome de Imunodeficiência Adquirida dos Símios/virologia , Vírus da Imunodeficiência Símia/patogenicidade , Replicação Viral
6.
Mucosal Immunol ; 5(6): 658-69, 2012 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-22669579

RESUMO

Innate lymphoid cells (ILCs) are an emerging subset of lymphocytes involved in surveillance against virally infected cells. Here, we show CD3(-)CD8(high) lymphocytes in macaque blood include major subsets of ILCs including natural killer (NK) cells expressing CD16, NKp46, and NKG2A, but also populations of ILCs in mucosal tissues having different properties. One ILC subset secreted interleukin (IL)-17 (ILC17), but these were restricted to mucosal tissues. Some mucosal ILC17 cells expressed classical NK-cell markers, but little NKG2A or NKG2D. Some ILC17 cells secreted IL-22 and tumor necrosis factor-α, but few produced interferon (IFN)-γ or contained granzyme B. IL-17 production by ILCs was induced by IL-6, transforming growth factor-ß, and IL-23. Further, simian immunodeficiency virus (SIV) infection resulted in a significant loss of ILC17 cells, especially in the jejunum, which persisted throughout SIV infection. These findings indicate that ILC17 cells may be involved in innate mucosal immune responses, and their loss may contribute to loss of intestinal mucosal integrity and disease progression in human immunodeficiency virus (HIV)/SIV infection.


Assuntos
Imunidade nas Mucosas , Mucosa Intestinal/imunologia , Jejuno/imunologia , Células Matadoras Naturais/imunologia , Síndrome de Imunodeficiência Adquirida dos Símios/imunologia , Vírus da Imunodeficiência Símia/fisiologia , Células Th17/imunologia , Animais , Antígenos CD/imunologia , Linhagem da Célula , Granzimas/imunologia , Granzimas/metabolismo , Interferon gama/imunologia , Interferon gama/metabolismo , Interleucina-17/deficiência , Interleucina-17/genética , Interleucina-17/imunologia , Interleucinas/deficiência , Interleucinas/genética , Interleucinas/imunologia , Mucosa Intestinal/patologia , Mucosa Intestinal/virologia , Jejuno/patologia , Jejuno/virologia , Células Matadoras Naturais/patologia , Células Matadoras Naturais/virologia , Contagem de Linfócitos , Depleção Linfocítica , Macaca mulatta , Subfamília C de Receptores Semelhantes a Lectina de Células NK/imunologia , Subfamília K de Receptores Semelhantes a Lectina de Células NK/imunologia , Síndrome de Imunodeficiência Adquirida dos Símios/patologia , Síndrome de Imunodeficiência Adquirida dos Símios/virologia , Células Th17/patologia , Células Th17/virologia , Fator de Necrose Tumoral alfa/imunologia , Fator de Necrose Tumoral alfa/metabolismo , Interleucina 22
7.
J Med Primatol ; 41(3): 191-201, 2012 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-22429048

RESUMO

Non-human primates (NHPs) are used to model human disease owing to their remarkably similar genomes, physiology, and immune systems. Recently, there has been an increased interest in modeling tuberculosis (TB) in NHPs. Macaques are susceptible to infection with different strains of Mycobacterium tuberculosis (Mtb), producing the full spectrum of disease conditions, including latent infection, chronic progressive infection, and acute TB, depending on the route and dose of infection. Clearly, NHPs are an excellent model of human TB. While the initial aim of the NHP model was to allow preclinical testing of candidate vaccines and drugs, it is now also being used to study pathogenesis and immune correlates of protection. Recent advances in this field are discussed in this review. Key questions such as the effect of hypoxia on the biology of Mtb and the basis of reactivation of latent TB can now be investigated through the use of this model.


Assuntos
Modelos Animais de Doenças , Macaca , Doenças dos Macacos/microbiologia , Mycobacterium tuberculosis/classificação , Tuberculose/microbiologia , Tuberculose/veterinária , Animais , Humanos , Mycobacterium tuberculosis/genética , Radiografia , Tuberculose/diagnóstico por imagem
8.
Neuropathol Appl Neurobiol ; 38(2): 162-74, 2012 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-21696421

RESUMO

AIMS: The pathogenesis of human/simian immunodeficiency virus encephalitis (HIVE/SIVE) remains incompletely understood, but is associated with alterations in the blood-brain barrier. At present, it is not possible to easily determine if an individual has HIVE/SIVE before post mortem examination. METHODS: We have examined serum levels of the astroglial protein S100ß in SIV-infected macaques and show that it can be used to determine which animals have SIVE. We also checked for correlations with inflammatory markers such as CCL2/MCP-1, IL-6 and C-reactive protein. RESULTS: We found that increased S100ß protein in serum correlated with decreased expression of the tight junction protein zonula occludens-1 on brain microvessels. Furthermore, the decrease in zonula occludens-1 expression was spatially related to SIVE lesions and perivascular deposition of plasma fibrinogen. There was no correlation between encephalitis and plasma levels of IL-6, MCP-1/CCL2 or C-reactive protein. CONCLUSIONS: Together, these data indicate that SIVE lesions are associated with vascular leakage that can be determined by S100ß protein in the periphery. The ability to simply monitor the presence of SIVE will greatly facilitate studies of the neuropathogenesis of AIDS.


Assuntos
Síndrome da Imunodeficiência Adquirida/sangue , Encefalite Viral/sangue , Encefalite Viral/diagnóstico , Monócitos/metabolismo , Fatores de Crescimento Neural/sangue , Proteínas S100/sangue , Síndrome da Imunodeficiência Adquirida/complicações , Animais , Biomarcadores/sangue , Barreira Hematoencefálica/patologia , Encéfalo/patologia , Proteína C-Reativa/metabolismo , Quimiocina CCL2/sangue , Encefalite Viral/complicações , Interleucina-6/sangue , Macaca mulatta , Proteínas de Membrana/metabolismo , Fosfoproteínas/metabolismo , Subunidade beta da Proteína Ligante de Cálcio S100 , Vírus da Imunodeficiência Símia , Junções Íntimas/metabolismo , Proteína da Zônula de Oclusão-1
9.
B-ENT ; 7(2): 121-5, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21838097

RESUMO

OBJECTIVES: To increase awareness of neuroendocrine adenomas of the middle ear (NAME), rare lesions often mistaken for other entities or chronic otitis media. Histogenesis remains controversial, although the consensus tends toward a pluripotent stem cell of the middle ear mucosa as the origin of the lesion. The tumour is characterised by dual differentiation with exocrine and endocrine components. The most common symptoms are conductive hearing loss, tinnitus and vertigo. The treatment of choice is complete surgical removal of the tumour with no adjuvant radiotherapy being required. CASE REPORT: We report the case of a 23-year-old man presenting with chronic otitis media, conductive hearing loss, vertigo and tinnitus who, some years previously, had suffered from an episode of facial nerve palsy. Conservative therapy failed and so surgery was performed. Tumour-like masses were encountered and histological and immunohistochemical examination revealed a neuroendocrine adenoma of the middle ear. CONCLUSION: This rare entity should be considered as differential diagnosis when treating chronic inflammatory disease not responding to conservative therapy or dealing with unclear expansive processes of the middle ear. MRI scans should be performed since CT scans are inconclusive.


Assuntos
Adenoma/diagnóstico , Neoplasias da Orelha/diagnóstico , Orelha Média , Paralisia Facial/diagnóstico , Tumores Neuroendócrinos/diagnóstico , Otite Média/diagnóstico , Adenoma/cirurgia , Audiometria , Doença Crônica , Diagnóstico Diferencial , Neoplasias da Orelha/cirurgia , Seguimentos , Humanos , Imageamento por Ressonância Magnética , Masculino , Tumores Neuroendócrinos/cirurgia , Procedimentos Cirúrgicos Otológicos/métodos , Tomografia Computadorizada por Raios X , Adulto Jovem
10.
Br J Cancer ; 104(8): 1303-12, 2011 Apr 12.
Artigo em Inglês | MEDLINE | ID: mdl-21407220

RESUMO

BACKGROUND: Activins and inhibins belong to the TGFß-superfamily, which controls cell proliferation and differentiation in many organs. Activin A, the dimer of inhibin ßA subunit, acts strongly anti-proliferative in hepatocytes. Little is known on the other activin/inhibin subunits in human liver and hepatocellular carcinoma (HCC). METHODS: We studied the expression of the complete inhibin family α, ßA, ßB, ßC, ßE in normal liver, tumour-adjacent and HCC tissue, 12 additional organs and rodent liver. A total of 16 HCC and 10 disease-free livers were analysed. Expression of inhibin subunits was determined by qRT-PCR, normalised to RNA input and by geNorm algorithm, and confirmed by immunohistochemistry. RESULTS: Remarkably, ßA expression was not decreased in HCC. Similarly, ßC and ßE exhibited no major changes. In contrast, inhibin α, barely detectable in normal liver, was strongly increased in tumour-adjacent liver and dramatically enhanced in HCC. ßB was strongly enhanced in some HCC. At variance with human liver, rodent liver showed higher inhibin α and ßC expression, but ßA was somewhat, and ßB dramatically lower. CONCLUSIONS: Upregulation of inhibin α - and possibly of ßB - may shield HCC cells from anti-proliferative effects of activin A. Dramatic variations between humans and rodents may reflect different functions of some inhibins/activins.


Assuntos
Ativinas/genética , Carcinoma Hepatocelular/genética , Inibinas/genética , Neoplasias Hepáticas/genética , Fígado/metabolismo , Roedores/genética , Ativinas/metabolismo , Adulto , Idoso , Animais , Carcinoma Hepatocelular/metabolismo , Carcinoma Hepatocelular/patologia , Estudos de Casos e Controles , Feminino , Expressão Gênica , Regulação Neoplásica da Expressão Gênica , Humanos , Inibinas/metabolismo , Neoplasias Hepáticas/metabolismo , Neoplasias Hepáticas/patologia , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Pessoa de Meia-Idade , Subunidades Proteicas/genética , Subunidades Proteicas/metabolismo , Ratos , Ratos Wistar , Roedores/metabolismo
12.
Mucosal Immunol ; 2(6): 518-26, 2009 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-19710637

RESUMO

Intestinal CD4+ T cells are rapidly and profoundly depleted in human immunodeficiency virus (HIV)-infected patients and simian immunodeficiency virus (SIV)-infected macaques. However, monitoring intestinal cells in humans is difficult, and identifying surrogate markers in the blood, which correlate with loss or restoration of intestinal CD4+ T cells could be helpful in monitoring the success of therapeutic strategies and vaccine candidates. Recent studies indicate HIV utilizes the intestinal homing molecule alpha4beta7 for attachment and signaling of CD4+ T cells, suggesting this molecule may have a central role in HIV pathogenesis. Here, we compared beta7(HIGH) integrin expression on CD4+ T cells in blood with loss of CD4+ T cells in the intestine of macaques throughout SIV infection. The loss of beta7(HIGH) CD4+ T cells in blood closely paralleled the loss of intestinal CD4+ T cells, and proved to be a more reliable marker of intestinal CD4+ T-cell loss than monitoring CCR5+ memory CD4+ T cells. These data are consistent with a recent hypothesis that alpha4beta7 has a role in the selective depletion of intestinal CD4+ T cells, and indicate that monitoring beta7(HIGH) expression on CD4+ T cells in the blood may be a useful surrogate for estimating intestinal CD4+ T cell loss and restoration in HIV-infected patients.


Assuntos
Biomarcadores/sangue , Linfócitos T CD4-Positivos/imunologia , Integrinas/biossíntese , Síndrome de Imunodeficiência Adquirida dos Símios/imunologia , Animais , Linfócitos T CD4-Positivos/metabolismo , Citometria de Fluxo , Imunidade nas Mucosas/imunologia , Imuno-Histoquímica , Integrinas/sangue , Mucosa Intestinal/imunologia , Macaca mulatta , Síndrome de Imunodeficiência Adquirida dos Símios/sangue
13.
J Laryngol Otol ; 123(4): 391-6, 2009 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-18588736

RESUMO

BACKGROUND: Congenital cytomegalovirus infection is the leading identified nongenetic cause of congenital sensorineural hearing loss. Most of the infections are asymptomatic but may be detected from umbilical cord vein and/or newborn serum positivity for human cytomegalovirus immunoglobulin M, and from urine positivity (on polymerase chain reaction) for human cytomegalovirus deoxyribonucleic acid in the newborn period. Children infected by cytomegalovirus may later develop sensorineural hearing loss. In symptomatically infected infants, ganciclovir therapy administered in the neonatal period prevents hearing deterioration. However, preventative therapy of asymptomatic congenital cytomegalovirus disease with ganciclovir is controversial, as side effects such as severe neutropenia may occur during treatment. METHODS: The study population consisted of 23 asymptomatic children with congenital cytomegalovirus infection. Twelve children were treated just after diagnosis of cytomegalovirus infection in the newborn period, with ganciclovir 10 mg/kg bodyweight for 21 days. The other 11 children were observed without therapy. Over a four to 10 year follow-up period, we evaluated all the children's hearing status using pure tone audiometry. RESULTS: All 23 children had normal sensorineural hearing at one year follow up. Five of the 23 children (21.7 per cent) were lost to follow up over the four to 11 year follow-up period. Of the remaining 18 children, sensorineural hearing loss occurred in two (11.1 per cent). Neither child had been treated with ganciclovir in the newborn period. An eight-year-old boy showed bilateral high frequency loss and a 10-year-old girl showed severe unilateral sensorineural hearing loss. In the ganciclovir-treated group (nine children), none showed sensorineural hearing loss. During ganciclovir therapy, moderate neutropenia occurred as a side effect in two out of 12 (16.6 per cent) treated children. Speech and general development were normal in all children. CONCLUSION: Asymptomatic congenital cytomegalovirus infection is likely to be a leading cause of sensorineural hearing loss in young children. Intravenous ganciclovir therapy seems to offer a medical option to prevent subsequent sensorineural hearing loss. Further studies including a greater number of children are needed. Cytomegalovirus screening models are mandatory if medical therapy is to be implemented in time.


Assuntos
Antivirais/uso terapêutico , Infecções por Citomegalovirus/congênito , Infecções por Citomegalovirus/tratamento farmacológico , Ganciclovir/uso terapêutico , Perda Auditiva Neurossensorial/prevenção & controle , Antivirais/administração & dosagem , Audiometria de Tons Puros , Criança , Pré-Escolar , Infecções por Citomegalovirus/complicações , Feminino , Seguimentos , Ganciclovir/administração & dosagem , Audição/efeitos dos fármacos , Perda Auditiva Neurossensorial/diagnóstico , Humanos , Recém-Nascido , Injeções , Masculino
14.
J Med Primatol ; 37(3): 109-15, 2008 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-18547256

RESUMO

BACKGROUND: Cryptosporidium infection leads to life-threatening diarrhea in AIDS patients. Pathogenesis of cryptosporidiosis is due to intestinal physiological alterations. We devised an ex-vivo model using ex-vivo Cryptosporidium parvum infection of jejunal tissues derived from SIV-infected macaques and studied the role of substance P (SP) in the pathogenesis of cryptosporidiosis. METHODS: We measured jejunal SP protein levels using ELISA, and electrophysiological alterations using the Ussing chamber technique in an ex vivo model of Cryptosporidium infection. Paraformaldehyde-fixed jejunum from SIV-infected macaques with and without naturally occurring cryptosporidiosis was studied for SP protein expression by immunohistochemistry and fluorescence deconvolution microscopy. RESULTS: Ex-vivo Cryptosporidium-infected tissues and tissues from SIV-infected macaques with naturally occurring cryptosporidiosis demonstrated elevated SP protein levels compared with tissues from SIV-infected animals without ex-vivo C. parvum infection or tissues from SIV-infected animals that have no evidence of cryptosporidiosis. In our ex-vivo model of Cryptosporidium infection, we demonstrated pathophysiological alterations that were blocked by SP-receptor antagonist treatment. CONCLUSIONS: These studies suggest that SP-receptor antagonists could prove useful for treatment of AIDS-related cryptosporidiosis.


Assuntos
Cryptosporidium parvum/fisiologia , Jejuno/fisiopatologia , Antagonistas dos Receptores de Neurocinina-1 , Síndrome de Imunodeficiência Adquirida dos Símios/complicações , Vírus da Imunodeficiência Símia , Animais , Criptosporidiose , Regulação da Expressão Gênica , Macaca , Substância P/genética , Substância P/metabolismo , Técnicas de Cultura de Tecidos
15.
Cell Immunol ; 248(2): 69-76, 2007 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-17980355

RESUMO

It has been well established that serotonin (5-hydroxytryptamine, 5-HT) plays a key role in neuro-endocrine-immune networks, mostly through its receptors and/or transporters. Although the presence of 5-HT receptor mRNAs in peripheral blood mononuclear cells (PBMCs) of rhesus monkeys has been reported, there is little information about serotonin transporter (SERT) expression by these cells. To examine SERT expression at the transcription and translation level, one-step RT-PCR, confocal microscopy and flow cytometry were used to detect SERT mRNA and protein expression by rhesus monkey PBMCs. It was found that SERT mRNA could be detected by RT-PCR from all of the rhesus macaque PBMC RNA samples and the nucleotide sequence of the amplicons was identical to the published SERT mRNA sequence. Low level SERT immunoreactivity was also demonstrated on the surface of rhesus PBMCs by confocal microscopy. Almost all lymphocytes and most monocytes were positive for SERT by flow cytometry. In the 2 rhesus macaques examined by multicolor flow cytometry, SERT(bright) cells were more than 84%, 94%, and 96% among CD20+, CD3+, and CD3+CD4+ lymphocytes respectively. These data demonstrate expression of SERT by rhesus macaque PBMCs, and indicate that rhesus macaques would be suitable models to test the in vivo immune regulatory effects of 5-HT or drugs targeting SERT.


Assuntos
Leucócitos Mononucleares/metabolismo , Proteínas da Membrana Plasmática de Transporte de Serotonina/biossíntese , Proteínas da Membrana Plasmática de Transporte de Serotonina/genética , Animais , Citometria de Fluxo , Macaca mulatta , Microscopia Confocal , RNA Mensageiro/biossíntese
16.
J Med Primatol ; 34(5-6): 237-42, 2005 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-16128918

RESUMO

It is known that there is disruption of the blood-brain barrier during terminal AIDS encephalitis in both human immunodeficiency virus (HIV)-infected humans and simian immunodeficiency virus (SIV)-infected rhesus macaques. Much, although by no means all, of the neuropathological findings of HIV and SIV infection involves accumulation of monocytes/macrophages that have likely crossed the blood-brain barrier (BBB). There is no convincing, rigorous, demonstration of HIV (or SIV) infecting endothelial cells in vivo. However, this is not to say that HIV infection would not have any effects on the physiology of microvascular brain endothelial cells. Because of the elaborate nature of cerebral microvessels, previous studies of cerebral endothelial cells have been constrained by sectioning artifacts. Examination of freshly isolated cerebral microvessels allows investigation of extended lengths of vessels (>150 mum) without sectioning artifacts. These studies determine the changes in the expression of the tight junction protein zo-1 protein on the endothelial cells of cerebral capillaries at terminal acquired immune deficiency syndrome, demonstrating that there is a decreased expression of zo-1 protein over extended lengths of microvessels.


Assuntos
Barreira Hematoencefálica/metabolismo , Macaca , Proteínas de Membrana/metabolismo , Doenças dos Macacos/metabolismo , Doenças dos Macacos/virologia , Fosfoproteínas/metabolismo , Síndrome de Imunodeficiência Adquirida dos Símios/metabolismo , Vírus da Imunodeficiência Símia , Animais , Barreira Hematoencefálica/virologia , Encéfalo/irrigação sanguínea , Endotélio Vascular/metabolismo , Expressão Gênica , Imuno-Histoquímica/veterinária , Junções Íntimas/metabolismo , Junções Íntimas/virologia , Proteína da Zônula de Oclusão-1
17.
Biochem Soc Trans ; 32(Pt 5): 750-2, 2004 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-15494005

RESUMO

The primary cell infected during acute HIV neuropathogenesis is the monocyte-derived macrophage. We have demonstrated that there is activation of the BBB (blood-brain barrier) during acute viral infection and at terminal AIDS. However, it has never been determined if there is a requirement for the virus to be carried through the BBB or how these Trojan horses would be induced to cross the BBB. We added SIVmac251-infected (SIV is simian immunodeficiency virus) mononuclear cells (and their supernatants) to the luminal or abluminal compartment of our BBB model. There was activation of both sides of the BBB model, only if viral-infected cells were added to the luminal compartment, as opposed to the addition of cell-free supernatants. This suggests that cell-associated virus is essential for the activation of the BBB. This, in turn, would be expected to lead to further infiltration of cells capable of viral infection. VCAM-1 (vascular cell adhesion molecule 1) staining revealed, for the first time, that there is an absolute requirement for virally infected cells, and not just the presence of virus for the activation of the BBB.


Assuntos
Barreira Hematoencefálica , Células Endoteliais/virologia , Vírus da Imunodeficiência Símia/fisiologia , Animais , Encéfalo/virologia , Leucócitos Mononucleares/virologia , Ligantes , Macaca , Microcirculação , Microscopia Confocal , Síndrome de Imunodeficiência Adquirida dos Símios/patologia , Vírus da Imunodeficiência Símia/metabolismo , Molécula 1 de Adesão de Célula Vascular/metabolismo
18.
Laryngorhinootologie ; 83(2): 117-21, 2004 Feb.
Artigo em Alemão | MEDLINE | ID: mdl-14999588

RESUMO

BACKGROUND: Fungal spores are frequent in air and their occurrence in the nasal mucus appears to be a common finding within the adult population, as we were able to show in recent studies. 91,3 % of CRS patients but also healthy controls grew positive fungal cultures out of their nasal mucus. The potential role of fungal elements in nasal mucus for the pathogenesis of CRS, with or without polyposis, is currently investigated intensely and discussed very controversially. However, it was still unknown, as of when fungi could be cultured from nasal mucus in humans. We attempted to identify this point of time, in the nasal mucus of neonates. METHODS: In our study we examined nasal mucus from 30 neonates immediately after birth, on the first and fourth day post partum, and after two and four months of life. The samples obtained with sterile cotton swabs were cultured on agar plates. Fungal cultures were identified either conventionally by microscopy or with molecular techniques. To show whether fungi in nasal mucus of newborns were acquired by contamination during birth, mucus of the maternal vagina was examined as well. RESULTS: Just after birth we found in 6 of 30 (20 %) of our neonates positive fungal cultures out of their nasal mucus, in 3 of them Candida albicans, probably due to contamination passing the maternal vagina as cultures of vaginal mucus of their mothers were positive for Candida albicans too. Positive fungal cultures were obtained in 2 of 29 (7 %) neonates on the second and in 4 of 26 (15 %) neonates on the fifth day of life. In all our cases initial presence in nasal mucus contamination just after birth or on the second day of life was limited to one day only. None of the 12 of 30 (40 %) neonates with positive fungal cultures from nasal mucus in the first 5 days of life showed clinical symptoms of nasal fungal colonisation. Besides Candida albicans, Penicillium sp., Cladosporium cladosporioides, Acremonium polychromum, Beauveria bassiana and Epicoccum nigrum could be detected in the first 5 days of life. After the second month of life, examination of nasal mucus yielded positive fungal cultures in 8 of 11 (72 %), after four months even 17 of 18 (94 %) of babies, with a wide array of different species. CONCLUSIONS: Fungi can be cultured from nasal mucus as soon as contact with the environmental air exists. Furthermore, a transfer of fungi from the mother's birth canal into the nose during birth is possible. Presence of fungal spores is common but not persistent in the nose of babies in the first days of life. However, after four months the situation is similar to the one in adults: fungal cultures can be obtained from almost everyone's nose. Therefore fungal spores must be considered a normal content of nasal mucus. Fungal spores are inhaled with every breath, some stick to the mucus, are transported to the nasopharynx and swallowed. This does not cause any clinical symptoms and is therefore not a pathological finding at all.


Assuntos
Fungos/isolamento & purificação , Muco/microbiologia , Mucosa Nasal/metabolismo , Rinite/microbiologia , Sinusite/microbiologia , Adulto , Fatores Etários , Doença Crônica , Humanos , Lactente , Recém-Nascido , Técnicas Microbiológicas , Mucosa Nasal/microbiologia , Esporos Fúngicos/isolamento & purificação
19.
Mycoses ; 46 Suppl 1: 23-7, 2003.
Artigo em Alemão | MEDLINE | ID: mdl-12955849

RESUMO

In the last fifty years, only 22 medical cases involving the basidiomycetous fungus Schizophyllum commune were reported. In a period of three years we have examined 270 patients suffering from chronic rhinosinusitis as well as from mycoses (fungus balls) within the paranasal sinuses. Either nasal mucus or fungal concrement from the sinuses were cultured and the resulting cultures identified microscopically. In cases, where a reliable identification of the fungi was not possible, DNA was extracted for molecular examination. The internal transcribed spacer (ITS) region of the ribosomal gene-cluster was amplified with fungus specific primers and sequenced thereafter. In addition, DNA of all fungi growing with sterile white mycelium was amplified with the primer pair scom1/scom2r, which is specific for S. commune. Altogether, within a three years period S. commune was isolated in twelve patients. It can be assumed, that with the presented methods S. commune will be found much more frequently in patients suffering from diseases of the nasal sinuses.


Assuntos
Micoses/microbiologia , Seios Paranasais/microbiologia , Schizophyllum/isolamento & purificação , Sinusite/microbiologia , Adulto , Doença Crônica , DNA Fúngico/análise , DNA Espaçador Ribossômico/análise , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Muco/microbiologia , Técnicas de Tipagem Micológica , Schizophyllum/classificação , Schizophyllum/genética
20.
Med Mycol ; 41(2): 149-61, 2003 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-12964848

RESUMO

The biodiversity of fungi isolated from the nasal mucus of patients suffering from chronic rhinosinusitis and from healthy persons was monitored over 28 months. Mucus samples were obtained by flushing the noses of patients with saline or by endoscopic sinus surgery. Fungi from mucus were cultivated on agar plates. Identification was performed microscopically and by polymerase chain reaction with subsequent sequencing of the ribosomal internal transcribed spacer region. Altogether, 619 strains of fungi were cultivated from 233 subjects. Eighty-one species were identified, with a maximum of nine different species per person. The most prevalent isolates belonged to the genera Penicillium, Aspergillus, Cladosporium, Alternaria and Aureobasidium. Whereas Aspergillus and Penicillium spp. occurred in more or less the same numbers throughout the year, Cladosporium spp., Alternaria spp. and Aureobasidium pullulans showed a significantly higher occurrence during late summer and early autumn.


Assuntos
Ecossistema , Fungos/isolamento & purificação , Muco/microbiologia , Rinite/microbiologia , Sinusite/microbiologia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Criança , Doença Crônica , DNA Fúngico/análise , DNA Espaçador Ribossômico/análise , Feminino , Fungos/classificação , Fungos/genética , Humanos , Masculino , Pessoa de Meia-Idade , Dados de Sequência Molecular , Técnicas de Tipagem Micológica , Mucosa Nasal/microbiologia , Reação em Cadeia da Polimerase , RNA Ribossômico 5,8S/genética , Análise de Sequência de DNA
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...